德國(guó)Geneart  www.geneart.com
Geneart是世界領(lǐng)先的合成基因制造商，是領(lǐng)先的合成生物學(xué)專(zhuān)家之一。　
Life Technologies收購(gòu)了德國(guó)合成基因制造商Geneart AG

GENEART, based in Regensburg/Bavaria, has become the global market leader ever since entering the gene synthesis market in 2000. In addition GENEART is one of the foremost global specialists in the area of Synthetic Biology today. The company provides the key technologies for pharmaceutical & biotechnology companies, chemical industry and academia for the development and production of new biotherapeutics, vaccines and improved industrial enzymes. Customers also take advantage of GENEART services to construct bacteria, which produce or break down complex biopolymers such as synthetics or petroleum components.
GENEART’s service portfolio is comprised of 3 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology (gene evolution) right through to the production of plasmid DNA. The entire service chain is DIN ISO 9001:2000 certified.
Gene Synthesis Services: GENEART provides in silico gene optimizations based on its proprietary GeneOptimizer® software. The respective gene sequences are produced using GENEART’s nano-scale high throughput GeneAssembler® technology platform.
Gene Evolution Services: Based on an optimized master gene the GENEART Gene Evolution Business Unit generates individual target-oriented gene variants and specific or randomized gene libraries via directed evolution. Such gene libraries may contain up to 100 billion (1011) variants of a master gene. This large number of variants is for example useful to identify improved drug candidates or industrial enzymes.
Plasmid Services: GENEART offers to insert (=clone) the produced synthetic genes and gene